A

Automated microinjection for zebrafish xenograft models

bioRxiv (Cold Spring Harbor Laboratory)

Abstract

Abstract Zebrafish xenograft models have been increasingly recognized for their ability to predict patient responses to cancer therapeutics, suggesting their potential as diagnostic tools in clinical settings. However, these models require the precise microinjection of cancer cell suspensions in many small and fragile zebrafish larvae. Manual injections are so challenging that, even after months of training, variability in experimental results persists among researchers. This limits the uptake and deployment of zebrafish xenograft models for clinical use and drug discovery. To address this challenge, we have designed, built, and validated an automated microinjection robot. Combined results of injections into the vasculature, perivitelline space, and hindbrain ventricle demonstrated an average injection success rate of approximately 60%, with a larvae survival rate exceeding 70%, comparable to manual injections using a traditional micromanipulator. Notably, the full automated mode was twice as fast as manual injections. This automation of the microinjection process significantly reduces the need for extensive personnel training while it enhances reproducibility, efficiency, and accuracy, paving the way for more extensive use of zebrafish xenograft models in drug discovery and patient diagnostics.

Authors 20

  1. Affiliation as printed

    Life Science Methods BV, Leiden, the Netherlands

  2. Affiliation as printed

    Life Science Methods BV, Leiden, the Netherlands

  3. University of Oslo

    Affiliation as printed

    Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway

  4. ZeClinics (Spain)

    Affiliation as printed

    ZeClinics SL, Barcelona, Spain

  5. BioReperia AB (Sweden)

    Affiliation as printed

    BioReperia AB, Linköping, Sweden

  6. Leiden University Medical Center

    Affiliation as printed

    Oncode Institute, Dept. Cell & Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands

  7. Leiden University Medical Center

    Affiliation as printed

    Oncode Institute, Dept. Cell & Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands

  8. Leiden University Medical Center

    Affiliation as printed

    Oncode Institute, Dept. Cell & Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands

  9. Affiliation as printed

    Life Science Methods BV, Leiden, the Netherlands

  10. BioReperia AB (Sweden)

    Affiliation as printed

    BioReperia AB, Linköping, Sweden

  11. University of Oslo

    Affiliation as printed

    Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway

  12. ZeClinics (Spain)

    Affiliation as printed

    ZeClinics SL, Barcelona, Spain

  13. ZeClinics (Spain)

    Affiliation as printed

    ZeClinics SL, Barcelona, Spain

  14. Leiden University Medical Center

    Affiliation as printed

    Oncode Institute, Dept. Cell & Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands

  15. University of Oslo

    Affiliation as printed

    Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway

  16. Linköping University · BioReperia AB (Sweden)

    Affiliation as printed

    BioReperia AB, Linköping, Sweden

    Division of Diagnostics and Specialist Medicine, Linköping University, Linköping, Sweden

  17. Jan de Sonneville corresponding
    Affiliation as printed

    Life Science Methods BV, Leiden, the Netherlands

Cited by 2 stored of 2

2 results

No patents citing this paper on Lens.org (checked 2026-10-11).

References 48